As states set record numbers of flu hospitalizations this year, healthcare professionals can expect this year’s flu season to continue into April, Dr. Gottlieb wrote.
To curb the high numbers of flu cases across the U.S. for next year, the FDA is teaming up with other public health agencies to produce next season’s flu vaccines and better understand why this year’s vaccines were not as effective against H3N2.
The agency is considering whether there should be greater investment in alternative processes, such as cell-based or recombinant approaches to vaccine development.
“By looking closely at the available data and applying the lessons we learn each flu season to the vaccine development process, we offer the greatest chance of developing vaccines that even more effectively prevent the flu in the future,” Dr. Gottlieb wrote.
More articles on infection control:
Colorado sees record-breaking number of flu hospitalizations
CDC seeks $350M to build new containment laboratory to study deadly pathogens
Researchers assess most cost-effective C. diff treatments — see how they stack up
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.